Estimating modifiable coronary heart disease risk in multiple regions of the world: The INTERHEART Modifiable Risk Score

European Heart Journal

Volumn 32, Issue 5, 2011, Pages 581-590

  McGorrian, Catherine ^a,b   Yusuf, Salim ^a   Islam, Shofiqul ^a   Jung, Hyejung ^a   Rangarajan, Sumathy ^a   Avezum, Alvaro ^c   Prabhakaran, Dorairaj ^d   Almahmeed, Wael ^e   Rumboldt, Zvonko ^f   Budaj, Andrzej ^g   Dans, Antonio L ^h   Gerstein, Hertzel C ^a   Teo, Koon ^a   Anand, Sonia S ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d CENTRE FOR CHRONIC DISEASE CONTROL   (India)

^e SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^f UNIVERSITY OF SPLIT   (Croatia)

^g GROCHOWSKI HOSPITAL   (Poland)

^h UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Ethnic; Global; Myocardial infarction; Prediction; Risk factors; Risk score

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CONTROLLED STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SMOKING; VALIDATION PROCESS; WAIST HIP RATIO;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; WORLD HEALTH;

EID: 79952335506     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq448     Document Type: Article

References (50)

1. World Health Organization. The atlas of heart disease and stroke. http://www. who.int/cardiovascular-diseases/resources/atlas/en/ (4 December 2009).
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case- control study. Lancet 2004;364:937-952. (Pubitemid 39208455)
3. Grundy SM, Paternak R, Greenland P, Smith S, Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;34:1348-1359. (Pubitemid 29500569)
4. Authors/Task Force Members, Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J, 2007, 28,2375-2414. (Pubitemid 47542237)
5. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005;111:499-510. (Pubitemid 40204436)
6. Wilson PF, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97: 1837-1847. (Pubitemid 28213628)
7. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njølstad I, Oganovj RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, on behalf of the SCORE project group1. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003. (Pubitemid 36712275)
8. McQueen M, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson J, Hasani M, Volkova E, Kazmi K, Yusuf S. Lipids, lipoproteins, and apo-lipoproteins as risk markers of myocardial infarction in 52 countries (the INTER-HEART study): A case-control study. Lancet 2008;372:224-233. (Pubitemid 351978112)
9. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-473. (Pubitemid 30126878)
10. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Ngu Blackett K, Sitthi-amorn C, Sato H, Yusuf S. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953-962. (Pubitemid 39208456)
11. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S, on behalf of the INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647-658. (Pubitemid 44223693)
12. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi M, Commerford P, Lang C, Rumboldt Z, Onen C, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS, for the INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649. (Pubitemid 41552419)
13. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba J, Al-Hinai A, Keltai M, Yusuf S, on behalf of the INTERHEART Study Investigators. Dietary patterns and the risk of acute myocardial infarction in 52 countries. Results of the INTERHEART Study. Circulation 2008;118:1929-1937.
14. Sullivan L, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med 2004;23:1631.
15. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassifica-tion and beyond. Stat Med 2008;27:157-172. (Pubitemid 351193639)
16. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
17. Thom TJ, Kannel WB, Silbershatz H, D'Agostino RB. Cardiovascular disease in the United States and preventive approaches. In: Fuster V, Alexander RW, O'Rourke RA, eds. Hurst's the Heart, Arteries and Veins. 10th ed. New York, NY: McGraw-Hill; 2001.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons, 1989.
19. Hosmer DW, Hosmer T, Lecessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997;16:965-980. (Pubitemid 27198985)
20. Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarksincriti-cal care: the Hosmer-Lemeshow test revisited. Crit care med 2007;35:2212-2213.
21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
22. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrox BN, Caski F, eds. Proceedings of the Second International Symposium on Information Theory, Budapest; 1973. p267-281.
23. Kass RE, Raftery AE. Bayes factors. J Am Stat Assoc 1995;90:773-795.
24. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-781. (Pubitemid 32722180)
25. Gerstein H.C. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 2004;47: 1519-1527. (Pubitemid 39371633)
26. Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc 1992;87: 178-183.
27. Marquardt D. Generalised inverses, ridge regression, biased liner estimation and nonlinear estimation. Technometrics 1970;12:591-612.
28. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 2009;150:65-72.
29. Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ 1999;319:1562-1565.
30. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008;54:17-23. (Pubitemid 351182592)
31. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882-890. (Pubitemid 38657490)
32. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipopro-tein B, low apolipoprotein A-I, and improvement in the prediction of fatal myo-cardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026.
33. Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein A1, the apolipoprotein B:A1 ratio and coronary heart disease: a literature-based meta analysis of prospective studies. J Int Med 2006;259:481-492.
34. Gaziano T, Young C, Fitzmaurice G, Atwood S, Gaziano J. Laboratory based versus non laboratory based method for assessment of cardiovascular disease risk: The NHANES I Follow-up Study cohort. Lancet 2008;371:923-931. (Pubitemid 351375276)
35. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care. The Fra-mingham Heart study. Circulation 2008;117:743-753. (Pubitemid 351640675)
36. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009;54:1209-1227.
37. Van Steenkiste B, Van der Weijden T, Timmermans DRM, Stoffers J, Grol R. Patients' ideas, fears and expectations of their coronary risk: barriers for primary prevention. Patient Educ Couns 2004;55:301-307. (Pubitemid 39458231)
38. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ 2009;338:b605.
39. Wyatt JC, Altman DG. Commentary: prognostic models: clinically useful or quickly forgotten? BMJ 1995;311:1539-1541.
40. Streiner DL. Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry 2002;47:262-266. (Pubitemid 34614684)
41. Harrell FE, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep 1985; 69:1071-1077. (Pubitemid 15249118)
42. Bays HE, Bazata DD, Clark NG, James G, Green A, Lewis S, Reed M, Stewart W, Chapman R, Fox K, Grandy S. Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (study to help improve early evaluation and management of risk factors leading to diabetes). BMC Public Health 2007;7:277.
43. Kehoe R, Wu SY, Leske MC, Chylack LT. Comparing self reported and physician-reported history. Am J Epidemiol 1994;139:813-818. (Pubitemid 24135785)
44. Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 1997;145:762-769. (Pubitemid 27175288)
45. Smith SC Jr, Greenland P, Grundy SM. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. Circulation 2000;101:111-116. (Pubitemid 30039085)
46. Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet 2003;362:1776-1777. (Pubitemid 37494752)
47. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92:1752-1759. (Pubitemid 44851316)
48. Montgomery AA, FaheyT, Peters TJ, MacIntosh C, Sharp DJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomized controlled trial. BMJ 2000;320:686-690. (Pubitemid 30179394)
49. Hall LML, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 2003;326:251-252. (Pubitemid 36169586)
50. Moons KM, Altman DG, Vergouwe Y, Royston P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009;338:b606.